Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: The use of nutritional supplements, such as selenium, may stop prostate cancer
from growing. Internal radiation, such as brachytherapy, uses radioactive material placed
directly into or near a tumor to kill tumor cells. Giving selenium before brachytherapy may
be an effective treatment for prostate cancer.
PURPOSE: This randomized phase I trial is studying selenium to see how well it works compared
to placebo in treating patients who are undergoing brachytherapy for stage I or stage II
prostate cancer.